Lipoprotein-associated phospholipase A2 is especially predictive of coronary artery disease among patients with the metabolic syndrome

被引：0
|
作者：
Lavasani, Farangis
May, Heidi T.
Horne, Benjamin D.
Anderson, Jeffrey L.
Carlquist, John F.
Wolfert, Robert L.
Pearson, Robert R.
Lanman, Richard B.
Muhlestein, Joseph B.
机构：
[1] LDS Hosp, Salt Lake City, UT USA
[2] Univ Utah, Salt Lake City, UT USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2007年 / 49卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：339A / 339A
页数：1
相关论文
共 50 条
  • [41] The role of lipoprotein-associated phospholipase A2 (Lp-PLA2)in the metabolic syndrome in diabetic patients
    Noto, Hiroshi
    Raskin, Philip
    [J]. DIABETES, 2006, 55 : A161 - A161
  • [42] Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease.
    Packard, CJ
    O'Reilly, DSJ
    Caslake, MJ
    McMahon, AD
    Ford, I
    Cooney, J
    Macphee, CH
    Suckling, KE
    Krishna, M
    Wilkinson, FE
    Rumley, A
    Lowe, GDO
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (16): : 1148 - 1155
  • [43] Lipoprotein-associated phospholipase A2 predicts heart failure hospitalization in coronary heart disease patients
    Ferreira, C.
    Baptista, R.
    Pego, J.
    Carmo, A.
    Ferreira, Ja
    Freitas, A.
    Milner, J.
    Martinho, S.
    Almeida, J. P.
    Campos, G.
    Rosa, J.
    Goncalves, L.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 : 331 - 331
  • [44] Lipoprotein-associated phospholipase A2 as a risk factor for coronary vascular disease in the elderly?
    Caslake, M. J.
    Cooney, J.
    Murray, E.
    Bedford, D.
    Robertson, M.
    Nelson, J. J.
    Packard, C. J.
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 484 - 484
  • [45] Lipoprotein-associated phospholipase A2:: An independent predictor of coronary artery disease events in primary and secondary prevention
    Anderson, Jeffrey L.
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2008, 101 (12A): : 23F - 33F
  • [46] Concentration of Lipoprotein-Associated Phospholipase A2 in Patients With Ischemic Heart Disease
    Noruzbaeva, A. M.
    Osmankulova, G. E.
    Aldashev, A. A.
    Mainazarova, E. S.
    [J]. KARDIOLOGIYA, 2016, 56 (01) : 49 - 50
  • [47] Lipoprotein-associated phospholipase A2 level in patients with Behcet's disease
    Orem, A.
    Yayli, S.
    Arica, D. A.
    Akcan, B.
    Yucesan, F. B.
    Bahadir, S.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2013, 27 (03) : e289 - e293
  • [48] Lipoprotein-associated phospholipase A2 as a biomarker of coronary heart disease and a therapeutic target
    Packard, Chris J.
    [J]. CURRENT OPINION IN CARDIOLOGY, 2009, 24 (04) : 358 - 363
  • [49] Decreased circulating lipoprotein-associated phospholipase A2 levels are associated with coronary plaque regression in patients with acute coronary syndrome
    Dohi, Tomotaka
    Miyauchi, Katsumi
    Okazaki, Shinya
    Yokoyama, Takayuki
    Ohkawa, Ryunosuke
    Nakamura, Kazuhiro
    Yanagisawa, Naotake
    Tsuboi, Shuta
    Ogita, Manabu
    Yokoyama, Ken
    Kurata, Takeshi
    Yatomi, Yutaka
    Daida, Hiroyuki
    [J]. ATHEROSCLEROSIS, 2011, 219 (02) : 907 - 912
  • [50] Decreased Circulating Lipoprotein-Associated Phospholipase A2 Levels Are Associated with Coronary Plaque Regression in Patients with Acute Coronary Syndrome
    Ogita, Manabu
    Miyauchi, Katsumi
    Dohi, Tomotaka
    Okazaki, Shinya
    Yokoyama, Takayuki
    Ohkawa, Ryunosuke
    Nakamura, Kazuhiro
    Tsuboi, Shuta
    Ogita, Manabu
    Yokoyama, Ken
    Kurata, Takeshi
    Yatomi, Yutaka
    Daida, Hiroyuki
    [J]. CIRCULATION, 2011, 124 (21)
12345